- Investor's Business Daily•10 hours ago
Regeneron and Sanofi argue Amgen's patents covering LDL-buster Repatha are too broad.
- GlobeNewswire•14 hours ago
Suliqua TM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Paris, France - January 18th , 2017 - Sanofi announced today that the European Commission has granted marketing ...
- Zacks•18 hours ago
Two important regulatory events scheduled in the first quarter of 2017.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||40.54 - 41.07|
|52 Week Range||36.81 - 44.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||23.81|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|